You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華檢醫療(01931.HK):974家醫院配備公司附屬安裝的Sysmex凝血分析儀
格隆匯 02-17 22:57

格隆匯2月17日丨華檢醫療(01931.HK)公佈,根據中國國家衞生健康委員會制定的《新型冠狀病毒感染的肺炎診療方案》,凝血分析在Covid-19及其他相關疾病的診斷及治療中起重要作用。自Covid-19爆發以來,集團一直依靠其凝血分析的專業知識積極參與抗疫。

根據中國內地當地機關發佈的相關數據,截至2020年2月16日,中國內地有2,108家醫院受指定治療Covid-19病人,其中,974家醫院(約佔46.2%)配備公司全資附屬公司威士達醫療設備(上海)有限公司安裝的Sysmex凝血分析儀,以進行凝血分析。

作為凝血分析的領先服務供應商,公司一直努力承擔企業社會責任。公司已指派326名專業技術人員和工程師(佔集團員工人數約56%)與前線醫護團隊緊密協作,以維持凝血分析儀的高效及有效運轉,滿足因Covid-19爆發對凝血分析的龐大需求。 

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account